1.31Open1.31Pre Close0 Volume3 Open Interest25.00Strike Price0.00Turnover31.68%IV2.99%PremiumSep 20, 2024Expiry Date0.58Intrinsic Value100Multiplier24DDays to Expiry0.73Extrinsic Value100Contract SizeAmericanOptions Type-0.5872Delta0.2011Gamma22.72Leverage Ratio-0.0145Theta-0.0082Rho-13.34Eff Leverage0.0242Vega
Life Time Stock Discussion
Select biotech/pharma names showing strength following ESMO:
$Clovis Oncology (CLVS.US)$ +11.3%, $Cardiff Oncology (CRDF.US)$ +9%, $Immatics (IMTX.US)$ +8.3%, $IDEAYA Biosciences (IDYA.US)$ +8%, $Lyra Therapeutics (LYRA.US)$ +5.7%, $POINT Biopharma (PNT.US)$ +5.7%, $Edgewise Therapeutics (EWTX.US)$ +4.7%, $Concert Pharmaceuticals (CNCE.US)$ +3.6%, $Deciphera Pharmaceuticals (DCPH.US)$ +3.2%, $Veracyte (VCYT.US)$ +2.6%, $SpringWorks Therapeutics (SWTX.US)$ +2.3%, ...
No comment yet